Initiatives yield decline in antipsychotic use across resident racial, ethnic groups: study
By
Alicia Lasek
May 01, 2023
Declining exposure to the drugs has occurred evenly across nursing home resident racial and ethnic groups, according to a new study.
CMS program had unintended outcome for Black residents with dementia, study suggests
By
Alicia Lasek
Oct 01, 2021
The rate of schizophrenia diagnoses rose significantly for Black nursing home residents with dementia after the CMS National Partnership to Improve Dementia Care launched in 2012, a new analysis finds.
Long-stay antipsychotic use reductions may require more scrutiny, study suggests
By
Dec 07, 2017
Reductions in antipsychotic use in long-stay nursing home residents may reflect more residents being diagnosed with mental health conditions excluded from quality measurement audits, a new study suggests.
Nursing home antipsychotic use has dipped nearly 19% under national effort, latest figures show
By
Tim Mullaney
Oct 31, 2014
The percent of long-stay nursing home residents receiving antipsychotic medication has decreased 18.8% under a nationwide initiative that started in 2012.
LTC achieves antipsych goal
By
Elizabeth Newman
May 01, 2014
After years of pushing, long-term care facilities have reduced their use of antipsychotic medication for dementia, according to an April report from the Centers for Medicare & Medicaid Services.
Long-term care providers achieved 15% antipsychotic reduction goal, CMS announces
By
Tim Mullaney
Apr 15, 2014
Long-term care facilities have reduced antipsychotic medication use by more than 15% through a large-scale initiative, according to a new report from the Centers for Medicare & Medicaid Services. That...
Facilities approach 15% goal for antipsychotics reduction
By
John O'Connor
Oct 01, 2013
For decades, many providers have viewed antipsychotic drugs as a necessary evil for treating residents with dementia. But increasingly, these medications are just being seen as evil. So it’s hardly...